Focusing on cutting-edge and gathering of big guys, bio S & T biomedical annual event will come in June! Sign up now and enjoy the benefits!

Time: June 18-20, 2019 Venue: W4 hall · Shanghai New International Expo Center · Shanghai · China organizer: China Chamber of Commerce for the import and export of medical and health products (CCCMHPIE), Shanghai UBM Sinoexpo, bosnan consulting support unit: Overview of American Chinese Biomedical Association (Caba), North American Chinese Biomedical Association (CABS), American Chinese Biomedical Technology Association (CBA), Chinese antibody Association (CAS), American Chinese Pharmaceutical Development Association (SAPA), overseas Chinese Entrepreneurs Association (Ocean) Bio S & T is a presentation of the exchange of new scientific ideas (Science) and new technological developments (Technology) in biopharmaceutics New conference and exhibition platform Closely tracking the development trend and hot topics of biopharmaceutical industry in recent years, it will be held in the same period as CPHI China 2019 (the 19th World pharmaceutical raw materials China Exhibition), which leads the pharmaceutical industry in Asia BioS&T We are committed to providing a platform for the high-speed development of biomedical industry to display and learn the latest information of biomedical industry on a regular basis The form of the platform is a combination of conference and exhibition, a three-day high-end biotechnology special meeting Meanwhile, we invite relevant biomedical enterprises to publicize and display their advanced technology concepts and product R & D directions during the meeting, and put individuals and enterprises, upstream and downstream experts Home and users together to help China connect with the world's leading biopharmaceutical industry In 2009, bio S & T was awarded the titles of American Chinese Biomedical Association (Caba), North American Chinese Biomedical Association (CABS), American Chinese Biomedical Technology Association (CBA), Chinese antibody Association (CAS), American Chinese Pharmaceutical Development Association (SAPA), overseas Chinese Entrepreneurs Association (Ocean) With the active participation and support of a number of high-end professional groups at home and abroad, we will work together to gather the most cutting-edge scientific and technological information and human resources of global biomedical industry, and jointly create the future of information sharing and mutually beneficial cooperation in the biomedical industry in China, the fastest-growing and most active stage in the global biomedical industry Many organizations participate in the event at the same time, and bio S & T will become an annual feast for 2019 biomedical industry! Form - "meeting" and "exhibition" linkage bio S & T will hold a three-day high-end biotechnology special meeting, focusing on three important areas of current biomedical industry, namely therapeutic monoclonal antibody, macromolecular GMP production and biotechnology investment, and inviting more than 30 industry leaders To form a luxury speech lineup, analyze the latest biotechnology trends in the world, explore and formulate international drug R & D strategies, share opportunities and challenges of biomedical enterprises at home and abroad, and realize project docking between the investment community and the industry In combination with bio S & T conference and exhibition, relevant enterprises are invited to set up exhibition areas at the same time of the conference, gather peers to show together, fully understand the development trend and trends of the industry, promote upstream and downstream enterprises to establish cooperative relations, and link the conference and exhibition, so as to maximize the effect of learning, communication and cooperation Topic introduction: the greatest biomedical invention of therapeutic mAbs, which has been widely used in clinical medicine in recent decades, has further promoted the development of this field in recent years In 2019, bio S & T will focus on the latest international technology development of this industry, share its experience and future plans with industry leaders, and a large number of Chinese newly created or newly transformed bio enterprises joining the field of monoclonal antibodies will also show their latest progress and demand for product production and financing in the next step The important bottleneck in the development of biopharmaceutical products in macromolecular GMP manufacturing involves complex procedures, high quality control requirements and large capital demand In recent years, the individual scale and overall production capacity of GMP production of macromolecular biopharmaceuticals have been expanded rapidly in China, but there are still challenges in technical depth, quality management and sustainable development In 2019, bio S & T will provide an opportunity to show and exchange, introduce the latest international technology and equipment, learn from the successful experience of the industry, and invite emerging enterprises in development to share their competitive advantages, so as to provide assistance for the development of biomedical industry Biotechnological investment capital controls the lifeblood of the development of biomedicine In recent years, a large number of funds have poured into China's biotechnological industry, which has developed rapidly in the short term At the same time, the valuation of enterprises and specific products has also greatly increased It is difficult to find the price of technological products with good investment potential and real innovation value In 2019, bio S & T will provide investors with a platform for direct communication with the most cutting-edge biological enterprises, in-depth understanding of the development of related fields and finding ideal investment opportunities Some speakers (ranking in no particular order): Liao Huaxin, chairman and chief scientist of therapeutic mAbs, Xu Ting, CEO of Zhuhai tenor Mabo Biotechnology Co., Ltd., Wang Jinsong, CEO of Suzhou Corning Jerry Biotechnology Co., Ltd., and Pt Pharmaceutical (Shanghai) Co., Ltd Shen Yuelei, CEO, Liu Yue, CEO of Beijing biosatellite gene Biotechnology Co., Ltd., ab studioinc.usa, Wang Xueping, general manager of Shanghai macromolecular R & D, Gu Jinming, deputy general manager of Jiangxi jimincredible Group Co., Ltd., Liu Shuying, CSO, Na biotech of Shanghai Qilu R & D center, USA Wu Hai, CSO, Zhou Weichang, chief technology officer, Steven Lee, founder and CEO, biogenexus, LLC Luo Shun, director general, biotechnology investment of aosikang bio Pharmaceutical (Haimen) Co., Ltd Cai Dajian, founder / Chairman, Lu Shengli, partner of Shenzhen gaotejia Investment Group Co., Ltd., Cheryl Cui, co-founder and partner of Yilian capital, nest bio Yao Cong, biological professional lawyer, American patent office * more speakers will update their participation scheme and participate in the exhibition in the same period Cphichina (world pharmaceutical raw materials China Exhibition) is the leading professional trade exchange event in the vertical industrial chain of the global pharmaceutical industry Since 2001, it has been introduced into China by Europe Bowen exhibition Consulting Co., Ltd., China Chamber of Commerce for the import and export of medical and health products and Shanghai Bohua International Exhibition Co., Ltd., deeply rooted in the pharmaceutical raw material industry, while continuously exploring the upstream and downstream industrial chains, extending the fields including biopharmaceuticals, laboratory instruments, pharmaceutical machinery, pharmaceutical packaging and other professional fields The scale of cphichina2019 exhibition will reach 200000 square meters, attracting more than 3000 exhibitors at home and abroad and more than 70000 professional visitors from more than 120 countries Bio S & T will further strengthen the technology and market promotion of macromolecular biological medicine industry on this large platform, and promote the contact between China and the world's biological system We: Ms Chen Sherry Tel: 021-33392262 email: sherry.chen@ubmsinoexpo.com website: http://www.cphi-china.cn/bio st